GlassScriptPhysician profile
Waqar Ahmad
NPI 1215077482
$1,048.63
in general payments reported to CMS, 2019-2025
15 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $11.48 · 2021: $224 · 2022: $183 · 2023: $302 · 2024: $67.05 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $381.92 | 2021-2023 | Venaseal |
| Abbvie INC. | $146.33 | 2021-2024 | |
| Baxter Healthcare | $142.86 | 2022-2023 | |
| Medtronic USA, INC. | $135.28 | 2019 | |
| Acera Surgical, INC. | $47.74 | 2024 | Restrata Wound Matrix |
| Boston Scientific Corporation | $30.07 | 2025 | General - Ep |
| Abbott Laboratories | $23.64 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.70 | 2022 | |
| Krystal Biotech INC | $22.65 | 2025 | Vyjuvek |
| Madrigal Pharmaceuticals | $22.27 | 2025 | Rezdiffra |
| Organogenesis INC. | $19.85 | 2019 | |
| Kerecis Limited | $16.01 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $14.18 | 2025 | Collagenase Santyl |
| Pfizer INC. | $11.65 | 2022 | |
| Allergan, INC. | $11.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waqar Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.